Abstract:Objective To explore the associations of serum expression of long non-coding RNA X-inactive specific transcript (lncRNA XIST) with the hepatitis B virus DNA (HBV-DNA) load and liver fibrosis in patients with hepatitis B.Methods A total of 87 cases with hepatitis B admitted to our hospital from June 2020 to June 2022 were included in the hepatitis B group, and 71 healthy people undergoing health checkups in the hospital during the same period were selected as the control group. Serum lncRNA XIST expression, HBV-DNA load and liver fibrosis markers [hyaluronic acid (HA), laminin (LN), type Ⅳ collagen (Ⅳ-C), type Ⅲ procollagen (PC-Ⅲ)] were measured in all the subjects. Pearson correlation analysis was used to explore the relationship of serum lncRNA XIST expression with the HBV-DNA load and liver fibrosis markers. The receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum lncRNA XIST for hepatitis B.Results The serum levels of TBil, ALT, AST, lncRNA XIST, HA, LN, Ⅳ-C and PC-Ⅲ in the hepatitis B group were higher than those in the control group (P < 0.05). Serum lncRNA XIST expression and levels of HA, LN, Ⅳ-C and PC-Ⅲ in hepatitis B patients with a high HBV-DNA load were higher than those in patients with a medium or low HBV-DNA load (P < 0.05), while they were even higher in patients with a medium HBV-DNA load compared to those with a low HBV-DNA load (P < 0.05). Pearson correlation analysis showed that the serum lncRNA XIST expression was positively correlated with the HBV-DNA load and levels of HA, LN, Ⅳ-C and PC-Ⅲ in hepatitis B patients (r = 0.445, 0.420, 0.369, 0.330, and 0.419, all P = 0.000). ROC curve results revealed that the sensitivity and specificity of serum lncRNA XIST for diagnosing hepatitis B were 80.65% (95% CI: 0.801, 0.811) and 88.74% (95% CI: 0.866, 0.908), respectively.Conclusions Serum lncRNA XIST expression is elevated in patients with hepatitis B, increases progressively with higher HBV-DNA load, and is closely associated with liver fibrosis, suggesting its potential as an effective clinical diagnostic marker for hepatitis B.